Divi's Laboratories Ltd
NSE:DIVISLAB

Watchlist Manager
Divi's Laboratories Ltd Logo
Divi's Laboratories Ltd
NSE:DIVISLAB
Watchlist
Price: 5 896.9502 INR 0.17%
Market Cap: 1.6T INR
Have any thoughts about
Divi's Laboratories Ltd?
Write Note
DIVISLAB
/
Balance Sheet
/
Deferred Income Tax

Divi's Laboratories Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Divi's Laboratories Ltd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Divi's Laboratories Ltd
NSE:DIVISLAB
Deferred Income Tax
₹5.8B
CAGR 3-Years
20%
CAGR 5-Years
63%
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Deferred Income Tax
₹15.5m
CAGR 3-Years
-79%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vimta Labs Ltd
NSE:VIMTALABS
Deferred Income Tax
₹780k
CAGR 3-Years
4%
CAGR 5-Years
-41%
CAGR 10-Years
-25%
I
Innova Captab Ltd
NSE:INNOVACAP
Deferred Income Tax
₹48.4m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Divi's Laboratories Ltd
Glance View

Market Cap
1.6T INR
Industry
Life Sciences Tools & Services

Divi's Laboratories Ltd. has carved an enviable niche for itself in the global pharmaceutical industry, with its origins tracing back to 1990 in Hyderabad, India. With a steadfast focus on research and development, the company stands as a formidable force in the Active Pharmaceutical Ingredients (APIs) and Intermediates manufacturing sector. Its strategy hinges on two complementary business segments: generic APIs and custom synthesis of APIs and intermediates. By catering to a broad spectrum of therapeutic areas, from cardiovascular ailments to pain management, Divi's capitalizes on economies of scale and technological innovation to produce cost-effective, high-quality pharmaceutical products. This strategy not only aligns with the company’s expertise in process development and chemical synthesis but also positions it as a key supplier to major pharmaceutical companies worldwide, providing a significant portion of their API requirements. The crux of Divi's financial engine lies in its custom synthesis segment, where it forms strategic alliances with global pharmaceutical giants, offering end-to-end solutions from drug discovery to commercialization. This vertical is fueled by long-term contracts that bolster the company’s revenue visibility and profitability. Meanwhile, the generic APIs segment benefits from the rising global demand for affordable healthcare solutions, particularly in emerging markets. Divi’s Laboratories leverages its state-of-the-art manufacturing facilities, which are compliant with international regulatory standards, to ensure efficient production cycles and maintain a consistent supply chain. Through its blend of innovative R&D, a robust manufacturing backbone, and strategic partnerships, Divi's Laboratories adeptly navigates the complexities of the pharmaceutical industry, making it a stalwart in the sector's supply chain ecosystem.

DIVISLAB Intrinsic Value
3 256.6378 INR
Overvaluation 45%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Divi's Laboratories Ltd's Deferred Income Tax?
Deferred Income Tax
5.8B INR

Based on the financial report for Jun 30, 2024, Divi's Laboratories Ltd's Deferred Income Tax amounts to 5.8B INR.

What is Divi's Laboratories Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
63%

Over the last year, the Deferred Income Tax growth was 8%. The average annual Deferred Income Tax growth rates for Divi's Laboratories Ltd have been 20% over the past three years , 63% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.